Shopping Cart
Remove All
Your shopping cart is currently empty
Ulenistamab (PBP1510) is a first-in-class humanized IgG1 monoclonal antibody targeting the pancreatic adenocarcinoma upregulated factor (PAUF), and is used in pancreatic cancer (PC) research [1].
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $290 | 2-4 weeks | 2-4 weeks | |
| 5 mg | $755 | 2-4 weeks | 2-4 weeks | |
| 10 mg | $1,200 | 2-4 weeks | 2-4 weeks |
| Description | Ulenistamab (PBP1510) is a first-in-class humanized IgG1 monoclonal antibody targeting the pancreatic adenocarcinoma upregulated factor (PAUF), and is used in pancreatic cancer (PC) research [1]. |
| In vitro | Ulenistamab (PBP1510) inhibits the proliferation of pancreatic cancer cell lines (CFPAC-1 and BxPC-3). Concurrently, there is a significant reduction in the migration and invasion of these cell lines [1]. |
| In vivo | The pharmacokinetic (PK) profiles and immunogenicity of Ulenistamab (PBP1510) (up to 20 mg/kg) were examined in a single-dose study involving 6 monkeys. Systemic exposure in the monkey study was observed to increase in a dose-proportional manner at both low and high doses [1]. |
| Synonyms | PBP1510 |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | < 1.0 EU/mg |
| Conjucates | Unconjugated |
| Cas No. | 2415259-90-2 |
| Storage | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.